Effect of FTY720 on the SET-PP2A complex in acute myeloid leukemia; SET binding drugs have antagonistic activity.
Hematology/Oncology Program, Center for Applied Medical Research (CIMA), University of Navarra, Navarra, Spain.
R
R
Pippa
Hematology/Oncology Program, Center for Applied Medical Research (CIMA), University of Navarra, Navarra, Spain.
A
A
Dominguez
Oncotide Pharmaceuticals, Research Triangle Park, NC, USA.
D J
DJ
Christensen
Hematology/Oncology Program, Center for Applied Medical Research (CIMA), University of Navarra, Navarra, Spain.
I
I
Moreno-Miralles
Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy, University of Navarra, Navarra, Spain.
M J
MJ
Blanco-Prieto
Oncotide Pharmaceuticals, Research Triangle Park, NC, USA.
M P
MP
Vitek
1] Hematology/Oncology Program, Center for Applied Medical Research (CIMA), University of Navarra, Navarra, Spain [2] Department of Biochemistry and Genetics, University of Navarra, Navarra, Spain.
M D
MD
Odero
D045744:Cell Line, Tumor; D004268:DNA-Binding Proteins; D000068876:Fingolimod Hydrochloride; D056488:Histone Chaperones / Q000502:physiology*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000201:enzymology; D010455:Peptides / Q000494:pharmacology; D011409:Propylene Glycols / Q000494:pharmacology*; D054648:Protein Phosphatase 2 / Q000037:antagonists & inhibitors*; D013110:Sphingosine / Q000031:analogs & derivatives* / Q000494:pharmacology; D014157:Transcription Factors / Q000502:physiology*
D004268:DNA-Binding Proteins; D056488:Histone Chaperones; C583613:OP449 peptide; D010455:Peptides; D011409:Propylene Glycols; C513473:SET protein, human; D014157:Transcription Factors; D054648:Protein Phosphatase 2; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine